• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于结肠给药的基于壳聚糖盐酸盐的阿苯达唑微球。

Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.

作者信息

Rai G, Jain S K, Agrawal S, Bhadra S, Pancholi S S, Agrawal G P

机构信息

Pharmaceutical Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar, India.

出版信息

Pharmazie. 2005 Feb;60(2):131-4.

PMID:15739902
Abstract

Microspheres of chitosan hydrochloride (CH) were prepared in order to deliver albendazole specifically into the colon. Microspheres were prepared by an emulsion method using different ratios of drug and CH (1:1 to 1:5), agitation speeds (500 to 1500 rpm) and concentrations of glutaraldehyde in toluene as the cross-linking agent (0.25 to 1.0% w/v). The effect of polymer concentration, stirring rate and concentration of cross-linking agent on the particle size and drug loading was studied. With an increase in CH concentration, the average particle size was increased. Increased agitation speed reduced the size of the microspheres but higher agitation speed resulted in irregularly shaped microspheres. Increasing the concentration of cross-linking agent produced more regularly shaped microspheres of smaller size. The drug loading was highest at a drug: CH ratio of 1:3, stirring speed 1000 rpm and 0.75% w/v concentration of cross-linking agent. The effect of CH concentration on in vitro drug release from the microspheres was evaluated in simulated g.i.t fluids. A comparative in vitro drug release study of the optimized formulation was carried out in simulated colonic fluid, with and without 2% rat caecal content. The drug release in 24 h was 48.9% in colonic fluid without rat caecal content, and 76.5% in colonic fluid with rat caecal contents.

摘要

制备了盐酸壳聚糖(CH)微球,以便将阿苯达唑特异性递送至结肠。采用乳液法,使用不同比例的药物与CH(1:1至1:5)、搅拌速度(500至1500转/分钟)以及甲苯中戊二醛作为交联剂的浓度(0.25至1.0%w/v)来制备微球。研究了聚合物浓度、搅拌速率和交联剂浓度对粒径和载药量的影响。随着CH浓度的增加,平均粒径增大。搅拌速度增加会减小微球尺寸,但更高的搅拌速度会导致微球形状不规则。增加交联剂浓度会产生尺寸更小、形状更规则的微球。在药物与CH比例为1:3、搅拌速度为1000转/分钟以及交联剂浓度为0.75%w/v时,载药量最高。在模拟胃肠道液中评估了CH浓度对微球体外药物释放的影响。在有和没有2%大鼠盲肠内容物的模拟结肠液中对优化制剂进行了体外药物释放对比研究。在没有大鼠盲肠内容物的结肠液中,24小时内药物释放率为48.9%,在含有大鼠盲肠内容物的结肠液中为76.5%。

相似文献

1
Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.用于结肠给药的基于壳聚糖盐酸盐的阿苯达唑微球。
Pharmazie. 2005 Feb;60(2):131-4.
2
Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.载有醋氯芬酸的壳聚糖微球的配方与评估用于结肠靶向药物传递。
Biopharm Drug Dispos. 2010 Oct;31(7):407-27. doi: 10.1002/bdd.722.
3
Colon specific chitosan microspheres for chronotherapy of chronic stable angina.用于慢性稳定型心绞痛时辰治疗的结肠定位壳聚糖微球。
Colloids Surf B Biointerfaces. 2011 Apr 1;83(2):277-83. doi: 10.1016/j.colsurfb.2010.11.033. Epub 2010 Dec 1.
4
Guar gum as a carrier for colon specific delivery; influence of metronidazole and tinidazole on in vitro release of albendazole from guar gum matrix tablets.瓜尔胶作为结肠特定给药的载体;甲硝唑和替硝唑对阿苯达唑从瓜尔胶基质片中体外释放的影响。
J Pharm Pharm Sci. 2001 Sep-Dec;4(3):235-43.
5
Multiresponse optimization of the properties of albendazole-chitosan microparticles.阿苯达唑-壳聚糖微粒性质的多响应优化
J Pharm Biomed Anal. 2008 Nov 4;48(3):802-7. doi: 10.1016/j.jpba.2008.08.006. Epub 2008 Aug 15.
6
Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.开发并鉴定载有 5-ASA 和盐酸卡米洛平的结肠靶向药物传递系统,用于溃疡性结肠炎的治疗。
J Drug Target. 2010 Sep;18(8):589-601. doi: 10.3109/10611860903572933.
7
Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.Eudragit包衣的壳聚糖-泼尼松龙缀合物微球在三硝基苯磺酸诱导的大鼠结肠炎模型中的胃肠道分布及吸收行为
Int J Pharm. 2008 Feb 4;348(1-2):80-8. doi: 10.1016/j.ijpharm.2007.07.007. Epub 2007 Jul 13.
8
Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm.化学变性法制备拉西地平胃滞留微球用于幽门痉挛。
J Microencapsul. 2009 Aug;26(5):385-93. doi: 10.1080/02652040802376429.
9
Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system.肠溶壳聚糖-泼尼松龙共轭微球的新型制备及其作为结肠给药系统潜力的体外评价
Eur J Pharm Biopharm. 2008 Feb;68(2):260-6. doi: 10.1016/j.ejpb.2007.06.016. Epub 2007 Jul 4.
10
Glutaraldehyde cross-linked chitosan microspheres for controlled delivery of zidovudine.戊二醛交联壳聚糖微球用于齐多夫定的控制释放。
J Microencapsul. 2009 May;26(3):214-22. doi: 10.1080/02652040802246325.

引用本文的文献

1
Formulation and optimisation of lamivudine-loaded Eudragit S 100 polymer-coated pectin microspheres for colon-specific delivery.载拉米夫定的 Eudragit S 100 聚合物包被果胶微球的配方与优化及其结肠定位给药。
IET Nanobiotechnol. 2021 Feb;15(1):90-99. doi: 10.1049/nbt2.12010. Epub 2021 Feb 2.
2
Design of chitosan and its water soluble derivatives-based drug carriers with polyelectrolyte complexes.基于聚电解质复合物的壳聚糖及其水溶性衍生物药物载体的设计
Mar Drugs. 2014 Dec 19;12(12):6236-53. doi: 10.3390/md12126236.
3
Effects of spray drying on physicochemical properties of chitosan acid salts.
喷雾干燥对壳聚糖酸盐水溶性的影响。
AAPS PharmSciTech. 2011 Jun;12(2):637-49. doi: 10.1208/s12249-011-9620-3. Epub 2011 May 11.
4
Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting.用于结肠靶向的5-氟尿嘧啶的聚丙烯酸树脂包衣果胶微球。
AAPS PharmSciTech. 2007 Feb 16;8(1):12. doi: 10.1208/pt0801012.